MedDataX Logo

Budesonide/Formoterol for Maintenance and Reliever Therapy Among Asthma Patients in Thailand

NCT ID: NCT00800241

Last Updated: 2010-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1020 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-05-31

Study Completion Date

2009-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the incidence of misuse, i.e., over-use and under-use, of Budesonide/formoterol for maintenance and reliever therapy in usual-care setting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Asthma Symbicort SMART Thai patient eligibility Persistent asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Established persistent asthma
* Currently treated with Symbicort SMART for 3 months or longer

Exclusion Criteria

* currently participating or have participated in a study with an investigational compound within the last 30 days
* current diagnosis of chronic obstructive pulmonary disease (COPD)
* smoked more than 10 pack-year
Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AstraZeneca (Thailand) Ltd.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bandit Thinkhamrop, PhD.

Role: PRINCIPAL_INVESTIGATOR

Department of Biostatistics and Demography, Faculty of Public Health, Khon Kaen University

Watchara Boonsawat, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Medicine, Faculty of Medicine, Khon Kaen University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Buriram, , Thailand

Site Status

Research Site

Chanthaburi, , Thailand

Site Status

Research Site

Chiang Mai, , Thailand

Site Status

Research Site

Mahasarakham, , Thailand

Site Status

Research Site

Nakhon Phanom, , Thailand

Site Status

Research Site

Nakhon Srithammarat, , Thailand

Site Status

Research Site

Nakhonpathom, , Thailand

Site Status

Research Site

Phatthalung, , Thailand

Site Status

Research Site

Phitsanulok, , Thailand

Site Status

Research Site

Rayong, , Thailand

Site Status

Research Site

Roi Et, , Thailand

Site Status

Research Site

Samutsakhon, , Thailand

Site Status

Research Site

Surat Thani, , Thailand

Site Status

Research Site

Trang, , Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-RTH-SYM-2008/1

Identifier Type: -

Identifier Source: org_study_id